medigraphic.com
ISSN 1561-2937 (Print)

2015, Number 3

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2015; 21 (3)

Left ventricular dysfunction and coronary artery bypass grafting

Flores SA, Rodríguez MA, Castillo MMP

Language: Spanish
References: 14
Page:
PDF size: 312.47 Kb.


ABSTRACT

Patients with ischemic cardiomyopathy have high risk in a short period of time after surgery and improvement of survival for a long time. It is necessary counterbalance the higher risk in the short period of time after surgery and posterior benefits. This bibliographic review was done with the purpose of knowing novel aspects about advantages and disadvantages of coronary artery bypass grafting in patients with left ventricular systolic dysfunction. Articles linked to theme and disposable in the last 8 years in Database like CUMED and PubMed/Medline were reviewed.Information was condensed, analyzed and resumed. Coronary surgery is associated with less cardiovascular mortality, hospitalizations for heart failure, improvement of functional class and quality of life. Higher risk immediately after coronary surgery is counterbalanced with the improvement of patients in postsurgical middle time and longtime. Coronary artery bypass grafting is very useful in patients with left ventricular systolic dysfunction.


REFERENCES

  1. Carson P, Wertheimer J, Miller A, O'Connor CM, Pina IL,Selzman C et al. Surgical treatment for Ischemic Heart Failure (STICH) Trial: mode of death results. JACC Heart Fail. 2013 October [citado 9 Sept 2015]; 1(5). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829618/

  2. Velázquez EJ, Bonow RO. Revascularization in severe left ventricular dysfunction. J Am Coll Cardiol 2015[citado9 Sept 2015];65:615–24. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25677320

  3. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011;364:1607-16.

  4. Jessup M, Acker MA. Surgical Management of Heart Failure. En: Douglas L. Mann, Douglas P. Zipes, Peter Libby, Robert O. Bonow, Eugene Braunwald. Braun-wald’s heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier Saunders, 2015,p.575-588.

  5. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al. Guía de práctica clinica de la ESC sobre revascularización miocárdica, 2014. Rev Esp Cardiol. 2015[citado 22 Sept 2015]; 68(2):144.e1–e95. Dispo-nible en: http://www.revespcardiol.org.

  6. Bonow RO. Indications for revascularization in pa-tients with left ventricular dysfunction: Evidence and uncertainties. J Thorac Cardiovasc Surg 2014[citado 9 Sept 2015];148:2461-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25433865

  7. Phillips HR, O’Connor CM, Rogers J. Revasculariza-tion for heart failure. Am Heart J 2007; 2007 Apr[citado 9 Sept 2015];153(4 Suppl):65-73. Dispon-ible en: http://www.ncbi.nlm.nih.gov/pubmed/17394905

  8. Bonow RO, Maurer G, Lee KL, Holly TH,Binkley PF,Desvine-Nickens P et al. Myocardial viability in ischemic left ventricular dysfunction. N Engl J Med 2011[citado 9 Sept 2015];364:1617-25. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290901/

  9. Panza JA, Velásquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR et al. Extent of coronary and myo-cardial disease and benefit from surgical revasculari-zation in LV dysfunction. J Am Coll Cardiol 2014[citado 9 Sept 2015];64:553–61. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25104523

  10. Gheorghiade M, Flaherty JD, Fonarow GC, Desai RV, Lee R, McGiffin D. Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure. Int J Cardiol. 2011 August 18[citado 9 Sept 2015]; 151(1): 69–75. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941707/

  11. Haxhibeqiri-Karabdic I, Hasanovic A, Kabil E, Straus S. Improvement of ejection fraction after coronary ar-tery bypass grafting surgery in patients with impaired left ventricular Function. Med Arh. 2014 Oct[citado 9 Sept 2015]; 68(5): 332-334. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269543/

  12. Wrobel K, Stevens SR, Jones RH, Selzman CH, Lamy A, Beaver TM et al. Influence of baseline characteris-tics, operative conduct, and postoperative course on 30-day outcomes of coronary artery bypass grafting among patients with left ventricular dysfunction: re-sults from the surgical treatment for ischemic heart failure (STICH) trial. Circulation. 2015 Aug 25[citado 9 Sept 2015];132(8):720-30. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/26304663

  13. Mark DB, Knight JD, Velazquez EJ, Wasilewski J, Howlett JG, Smith PK et al. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. Ann Intern Med. 2014 Sep 16[citado 9 Sept 2015];161(6):392-9. Disponible en: http://annals.org/article.aspx?articleid=1905127

  14. Stewart RA, Szalewska D, She L, Lee KL, Drazner MH, Lubiszewska B et al. Exercise capacity and mor-tality in patients with ischemic left ventricular dys-function randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). JACC: Heart Failure 2014 Aug[citado 9 Sept 2015]; 2(4):335-43. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127151/




2020     |     www.medigraphic.com